Format

Send to

Choose Destination
Neurology. 2001 Oct 9;57(7):1313-6.

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.

Author information

1
Department of Neurology, University of Rochester, NY 14642, USA. gschifitto@mct.rochester.edu

Abstract

HIV-associated distal sensory polyneuropathy (DSP) is a common complication of AIDS. No effective treatment is available. The authors investigated the long-term effect (48 weeks) of the neurotrophin nerve growth factor (NGF) in an open-label study of 200 subjects with HIV-associated DSP. Similar to their previously reported double-blind study, the authors showed that NGF was safe and well tolerated and significantly improved pain symptoms. However, there was no improvement of neuropathy severity as assessed by neurologic examination, quantitative sensory testing, and epidermal nerve fiber density.

PMID:
11591856
DOI:
10.1212/wnl.57.7.1313
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center